*	OR T3 T4 T5 T6
R1	Has_qualifier Arg1:T1 Arg2:T2	
R2	Subsumes Arg1:T1 Arg2:T3	
R3	Has_multiplier Arg1:T11 Arg2:T12	
*	OR T10 T11
R4	Has_value Arg1:T9 Arg2:T10	
R5	multi Arg1:T17 Arg2:T16	
R6	Has_value Arg1:T14 Arg2:T15	
R7	Has_qualifier Arg1:T14 Arg2:T17	
*	OR T9 T14
R8	AND Arg1:T8 Arg2:T9	
R9	Has_value Arg1:T20 Arg2:T21	
R10	Has_temporal Arg1:T20 Arg2:T19	
R11	Has_index Arg1:T25 Arg2:T26	
*	OR T22 T23
R12	Has_qualifier Arg1:T22 Arg2:T24	
R13	Has_temporal Arg1:T22 Arg2:T25	
R14	Has_qualifier Arg1:T30 Arg2:T29	
R15	Has_temporal Arg1:T30 Arg2:T28	
R16	Has_qualifier Arg1:T30 Arg2:T31	
R17	Has_index Arg1:T32 Arg2:T33	
R18	Has_temporal Arg1:T30 Arg2:T32	
*	OR T34 T37 T36
R19	Has_temporal Arg1:T34 Arg2:T35	
R20	Has_qualifier Arg1:T34 Arg2:T38	
*	OR T40 T41
R21	Has_qualifier Arg1:T40 Arg2:T42	
R22	Has_qualifier Arg1:T46 Arg2:T47	
R23	Has_temporal Arg1:T46 Arg2:T45	
R24	Has_qualifier Arg1:T48 Arg2:T49	
R25	Has_temporal Arg1:T48 Arg2:T50	
R26	Has_index Arg1:T50 Arg2:T51	
R27	Has_qualifier Arg1:T52 Arg2:T53	
R28	Has_index Arg1:T54 Arg2:T55	
R29	Has_temporal Arg1:T52 Arg2:T54	
R30	Has_qualifier Arg1:T56 Arg2:T57	
R31	Has_value Arg1:T58 Arg2:T59	
R32	AND Arg1:T56 Arg2:T58	
R33	Has_temporal Arg1:T56 Arg2:T60	
R34	Has_context Arg1:T62 Arg2:T63	
R35	Has_qualifier Arg1:T62 Arg2:T61	
*	OR T65 T66
R36	Has_multiplier Arg1:T67 Arg2:T65	
*	OR T70 T71
R37	multi Arg1:T76 Arg2:T75	
*	OR T76 T77
R38	Has_temporal Arg1:T76 Arg2:T74	
R39	Has_qualifier Arg1:T76 Arg2:T78	
R40	Has_qualifier Arg1:T80 Arg2:T81	
R41	Has_qualifier Arg1:T83 Arg2:T84	
R42	Has_temporal Arg1:T83 Arg2:T82	
R43	Has_value Arg1:T90 Arg2:T89	
R44	Has_temporal Arg1:T92 Arg2:T93	
R45	Has_value Arg1:T92 Arg2:T91	
R46	AND Arg1:T97 Arg2:T98	
T1	Condition 0 47	Active proliferative diabetic retinopathy (PDR)
T2	Qualifier 48 64	in the study eye
T3	Condition 73 76	NVE
T4	Condition 78 81	NVD
T5	Condition 83 102	vitreous hemorrhage
T6	Condition 107 127	neovascular glaucoma
T8	Condition 129 154	Uncontrolled hypertension
T9	Measurement 166 174	systolic
T10	Value 175 184	>180 mmHg
T11	Value 188 198	> 160 mmHg
T12	Multiplier 199 228	on 2 consecutive measurements
T14	Measurement 232 241	diastolic
T15	Value 242 252	> 100 mmHg
T16	Procedure 256 279	optimal medical regimen
T17	Qualifier 253 279	on optimal medical regimen
T19	Temporal 280 289	Screening
T20	Measurement 290 306	HgA1c blood test
T21	Value 307 313	> 10.0
T22	Procedure 314 342	Focal laser photocoagulation
T23	Drug 346 378	intravitreal/periocular steroids
T24	Qualifier 391 407	in the study eye
T25	Temporal 408 457	within the last 90 days prior to study enrollment
T26	Reference_point 441 457	study enrollment
T28	Temporal 461 471	history of
T29	Qualifier 472 484	intravitreal
T30	Procedure 485 504	anti-VEGF injection
T31	Qualifier 517 533	in the study eye
T32	Temporal 534 583	within the last 45 days prior to study enrollment
T33	Reference_point 567 583	study enrollment
T34	Condition 596 629	rhegmatogenous retinal detachment
T35	Temporal 585 595	History of
T36	Condition 631 646	retinal tear(s)
T37	Condition 651 679	traction retinal detachments
T38	Qualifier 680 696	in the study eye
T40	Condition 698 717;739 747	Epiretinal membrane traction
T41	Condition 725 747	vitreomacular traction
T42	Qualifier 748 764	in the study eye
T43	Non-representable 765 808	as determined by the central reading center
T45	Temporal 810 818	Previous
T46	Procedure 819 840	pars plana vitrectomy
T47	Qualifier 841 857	in the study eye
T48	Procedure 862 881	intraocular surgery
T49	Qualifier 882 898	in the study eye
T50	Temporal 899 948	within the last 90 days prior to study enrollment
T51	Reference_point 932 948	study enrollment
T52	Procedure 950 969	YAG laser treatment
T53	Qualifier 970 986	in the study eye
T54	Temporal 987 1028	in last 30 days prior to study enrollment
T55	Reference_point 1012 1028	study enrollment
T56	Condition 1030 1041	High myopia
T57	Qualifier 1042 1058	in the study eye
T58	Measurement 1067 1087	spherical equivalent
T59	Value 1091 1097	>8.00D
T60	Temporal 1098 1110	at screening
T61	Qualifier 1111 1116	Other
T62	Condition 1117 1135	ocular pathologies
T63	Observation 1171 1229	would interfere with the subject's vision in the study eye
T64	Non-query-able 1141 1170	in the investigator's opinion
T65	Multiplier 1231 1238	Chronic
T66	Multiplier 1242 1251	recurrent
T67	Condition 1252 1259	uveitis
T69	Temporal 1261 1268	Ongoing
T70	Condition 1269 1285	ocular infection
T71	Condition 1269 1275;1289 1301	ocular inflammation
T72	Qualifier 1302 1315	in either eye
T74	Temporal 1319 1329	history of
T75	Procedure 1330 1346	cataract surgery
T76	Condition 1330 1360	cataract surgery complications
T77	Condition 1361 1374	vitreous loss
T78	Qualifier 1375 1391	in the study eye
T80	Condition 1393 1421	Congenital eye malformations
T81	Qualifier 1422 1438	in the study eye
T82	Temporal 1442 1452	history of
T83	Condition 1453 1478	penetrating ocular trauma
T84	Qualifier 1479 1495	in the study eye
T85	Condition 1497 1517	Mentally handicapped
T86	Condition 1519 1527	Pregnant
T87	Person 1528 1534	female
T88	Person 1554 1559	women
T89	Value 1560 1578	less than 60 years
T90	Person 1579 1582	old
T91	Value 1588 1596	positive
T92	Measurement 1597 1617	urine pregnancy test
T93	Temporal 1618 1645	during the screening window
T94	Observation 1647 1654	Nursing
T95	Person 1655 1661	female
T96	Competing_trial 1663 1724	Currently participating in any other clinical research study.
T97	Condition 1725 1741	Contraindication
T98	Drug 1749 1765	study medication
